创建人工智能药物发现引擎

IF 12.6 1区医学 Q1 ALLERGY

Allergy Pub Date : 2024-09-13 DOI:10.1038/d41573-024-00149-6

Asher Mullard

引用次数: 0

摘要

Recursion 首席研发官兼首席商务官纳贾特-汗（Najat Khan）讨论 Recursion 和 Exscientia 的合并方案。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

Creating an AI-first drug discovery engine

查看原文本刊更多论文

Creating an AI-first drug discovery engine

Najat Khan — Chief R&D Officer and Chief Commercial Officer at Recursion — discusses the proposed merger of Recursion and Exscientia. Najat Khan — Chief R&D Officer and Chief Commercial Officer at Recursion — discusses the proposed merger of Recursion and Exscientia.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Allergy 医学-过敏

CiteScore

26.10

自引率

9.70%

发文量

393

审稿时长

2 months

期刊介绍： Allergy is an international and multidisciplinary journal that aims to advance, impact, and communicate all aspects of the discipline of Allergy/Immunology. It publishes original articles, reviews, position papers, guidelines, editorials, news and commentaries, letters to the editors, and correspondences. The journal accepts articles based on their scientific merit and quality. Allergy seeks to maintain contact between basic and clinical Allergy/Immunology and encourages contributions from contributors and readers from all countries. In addition to its publication, Allergy also provides abstracting and indexing information. Some of the databases that include Allergy abstracts are Abstracts on Hygiene & Communicable Disease, Academic Search Alumni Edition, AgBiotech News & Information, AGRICOLA Database, Biological Abstracts, PubMed Dietary Supplement Subset, and Global Health, among others.